Current Treatment Options in Neurology (ISSN 1092-8480) is a bimonthly, peer-reviewed journal published by Springer in the United States, dedicated to advancing clinical practice in the field of neurology through the synthesis of current therapeutic strategies. As a non-open access publication indexed in the Science Citation Index (SCI), the journal focuses exclusively on comprehensive reviews of treatment modalities for major neurological conditions, including cerebrovascular diseases, neurodegenerative disorders, epilepsy, and multiple sclerosis. By featuring contributions primarily from leading experts in the field, it provides clinicians and researchers with high-quality, evidence-based insights into the latest available treatment options, although readers are encouraged to supplement these reviews with the most recent primary research to account for the inherent lag in review-based publications. While its specific impact factor and CAS journal ranking fluctuate annually and require consultation of the latest JCR reports and partition tables for precise metrics, the journal maintains a strong reputation for delivering authoritative, clinically relevant overviews that bridge the gap between emerging scientific evidence and practical medical application.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com